Outcomes of relapse after teclistamab therapy in multiple myeloma

Affiliations

• ¹ Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
• ² Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ³ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁴ Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁵ Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁶ Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.
• ⁷ Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Sandra.SusanibarAdaniya@pennmedicine.upenn.edu.
• ⁸ Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Sandra.SusanibarAdaniya@pennmedicine.upenn.edu.